Evidence Shows HepDirect Prodrugs Are a Way to Target Drugs to the Liver
Metabasis Therapeutics has announced that an article titled, "Liver-Targeted
Drug Delivery Using HepDirect Prodrugs," was published in the February
issue of The Journal of Pharmacology and Experimental Therapeutics.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.